by Nancy Cohen , Medical Xpress A study conducted by Evidation Health on behalf of Eli Lilly and Apple suggests that data collected from smart devices and digital apps might help speed up the diagnosis of early stages of Alzheimer’s disease. The study, “Developing Measures of Cognitive Impairment in the Real World from Consumer-Grade Multimodal...
Tag: <span>Alzheimer’s disease</span>
Post
Transcranial Electromagnetic Treatment Halts, Reverses Alzheimer’s
MEDGADGET EDITORSMEDICINE, NEUROLOGY, NEUROSURGERY, REHAB The MemorEM system from NeuroEM Therapeutics, a company based in Phoenix, Arizona, delivers transcranial electromagnetic treatment, or TEMT, to the brains of patients in two one-hour sessions each day for two months. This involves propagating electromagnetic waves toward β-amyloid aggregates that seem to be responsible for the symptoms of Alzheimer’s....
Post
New drug targets early instigator of Alzheimer’s disease
by Arizona State University Over a hundred years after they were first identified, two ominous signposts of Alzheimer’s disease (AD) remain central topics of research—both formed by sticky accumulations of protein in the brain. Amyloid beta solidifies into senile plaques, which congregate in the extracellular spaces of nerve tissue, while tau protein creates tangled forms crowding the bodies...
Post
Alzheimer’s: Death of key brain cells causes daytime sleepiness
Published TodayBy Maria Cohut Fact checked by Gianna D’Emilio Extreme daytime sleepiness is often a top symptom of Alzheimer’s disease but what, exactly, causes it? New research finally brings us an answer. A specific type of protein may cause daytime sleepiness in people with Alzheimer’s, according to a recent study. Many people with Alzheimer’s disease have a tendency to...
Post
The brain’s amyloid buildup is not a powerful indicator of Alzheimer’s disease
Posted Today While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer’s disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, according to a new study from researchers in the Perelman School of Medicine and Thomas Jefferson University. The researchers concluded that...
Post
The Medical Minute: Take steps to slow Alzheimer’s disease
by Pennsylvania State University Alzheimer’s disease is the most common type of dementia. It slowly kills brain cells and is the fifth-leading cause of death for Americans age 65 and older. But contrary to popular belief, steps can be taken to slow it down. “People think Alzheimer’s is an entirely genetic disorder, but most often, it’s not,” said Dr. Charles Duffy, a neurologist at...
Post
Hormone Therapy for Prostate Cancer May Raise Risk of Alzheimer’s, Dementia
Posted Today For patients with prostate cancer, treating the disease with androgen deprivation therapy (ADT) is linked to a higher likelihood of being diagnosed with Alzheimer’s disease or dementia, compared to patients who do not receive the therapy, according to a study from researchers in the Perelman School of Medicine at the University of Pennsylvania. The results were published in JAMA. Of the...
Post
Alzheimer’s drug trial targets by-product of gum disease
by Alzheimer’s Research UK The pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer’s drug that targets toxic substances released by P. gingivalis, a bacteria linked to gum disease. In a poster presented at the Alzheimer’s Association International Conference today (Wednesday, July 17), researchers provided an overview of the development of the drug, known as COR388, and how they are working to test its ability to slow the progression...
Post
Moments of clarity in dementia patients at end of life: Glimmers of hope?
by University of Michigan It happens unexpectedly: a person long thought lost to the ravages of dementia, unable to recall the events of their lives or even recognize those closest to them, will suddenly wake up and exhibit surprisingly normal behavior, only to pass away shortly thereafter. This phenomenon, which experts refer to as terminal or...
Post
Scientists map elusive toxic proteins linked to Alzheimer’s, providing new molecular clues for prevention
A team of researchers from McMaster University has mapped at atomic resolution a toxic protein linked to Alzheimer’s disease, allowing them to better understand what is happening deep within the brain during the earliest stages of the disease. The findings, published on the front cover of the current edition of the Royal Society of Chemistry flagship journal Chemical Science, provide new insights...